HIV Flashcards
Seven stages of HIV life cycle
Binding - virus binds to CD4 cell
Fusion - once bound, can insert its RNA into host cell
Reverse Transcription - transforms viral RNA to DNA and is now able to enter host nucleus
Integration - inserts its DNA into host DNA
Replication - uses CD4 cell to make long chains of HIV proteins which are building blocks for more HIV
Assembly - these proteins and HIV RNA move to surface of the cell and assemble into immature HIV
Budding - the immature HIV exits CD4 cell, it then releases protease which breaks up the long pro chains into smaller ones which then combine to form mature HIV
Normal CD4 count
500-1500
When are opportunistic infections likely to strike (CD4 count)
Less than 500
Clinical Course of HIV
Early infection (acute)
Clinical Latency (Chronic)
Rapid virus production (converts to AIDS)
Early infection (Acute) s/sxs
rapid replication not detectable by lab tests no symptoms infectious Seroconversion (3 wks-6 months) antibodies are detectable flu-like sxs for several weeks highly infectious
large amounts of virus in body during this stage
Clinical Latency s/sxs
virus levels have stabilized
body is fighting infections
3-12 years
asymptomatic or mild sxs (enlargements of lymph nodes, fatigue, etc.)
HIV reproduces at very low levels, but still active
Rapid virus production s/sxs
persistent drop in CD4 T-cell counts
antiviral fight becomes less effective
viral load increases–immune system declines
symptomatic HIV infection–AIDS
AIDS-defining illnesses
Fungal
Candidiasis (pulmonary, esophageal) NOT oral
Pneumcystitis jiroveci pneumonia
Viral CMV Herpes simplex chronic ulcer > 1 month pulmonary/esophageal
Protozoal
Toxoplasmosis
Isosporiasis
Cryptosporidiosis (intestinal)
Bacterial
Mycobacterium (TB, avium)
PNA, recurrent
Salmonella septicemia, recurrent
Cancers
Kaposi’s sarcoma
Cervical CA (invasive)
Lymphomas
Other
Wasting syndrome
Encephalopathy
AIDS dementia complex
AIDS diagnosis
CD4 count < 200 OR has an AIDS defining illness
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
MOA and toxicities
zidovudine (Retrovir) (AZT)
inhibits reverse transcriptase thus preventing viral DNA from being produced
severe anemia and neutropenia–may need multiple blood transfusions and tx stopped
lactic acidosis in female or obese patients
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
MOA, AE
efavirenz (Sustiva)
Inhibits reverse transcriptase, works directly against the enzyme
rash - 30% develop; if severe, drug should be halted
CNS sxs - take at night to reduce effects
Lots of drug interactions
Integrase Inhibitor
raltegravir (Isentress)
Often used when pts have drug resistant HIV, can also dev. resistance to this drug
Well Tolerated
Drug interations (UGT enzyme)
Protease Inhibitors
lopinavir/ritonavir (Kaletra)
AE: hyperglycemia, lipdystrophy, hyperlipidemia, bone loss
Drug interactions
Fusion Inhibitor
enfuvirtide (Fuzeon)
Blocks entry of HIV into CD4 t-cells
Given SQ BID
injection site rxs, pna, hypersensitivity
no significant drug interactions
CCR5 Antagonist
maraviroc (Selzentry)
Blocks entry into CD4 cell that uses the CCR5 to gain access
Black Box Warning: liver injury (preceded with s/sxs of allergic rx
only used in pts who are resistant and must have blood test showing they have the correct strain that uses this method
Monitor liver labs
Drug interactions